Literature DB >> 2474608

Monoclonal antibodies that bind to distinct epitopes on Fc gamma RI are able to trigger receptor function.

P M Guyre1, R F Graziano, B A Vance, P M Morganelli, M W Fanger.   

Abstract

The human monocyte and macrophage Fc receptor that binds human IgG with high affinity is a surface glycoprotein with a relative molecular mass of approximately 70 kDa. This receptor (Fc gamma RI) has been partially characterized using mAb 32 which binds outside the Fc binding domain of the receptor, but nonetheless triggers Fc receptor-dependent functions. In this study, we describe the properties of four new antibodies with specificity for Fc gamma RI. Based on additivity and cross-blocking studies, we conclude that two of these antibodies (mAb 22 and 44) define a third epitope which is distinct from the binding sites for both mAb 32 and the Fc portion of human IgG. Each Fc gamma RI-specific hybridoma was selected for stable sublines expressing high levels of mAb on the cell surface, and then tested for the ability of this surface mAb to trigger antibody-dependent cell cytotoxicity. All sublines were killed by human monocytes when used as targets in a 51Cr-release assay, whereas hybridomas specific for myeloid Ag other than Fc gamma RI were not killed. We conclude that Fc receptor function is triggered through binding to each of the three epitopes of Fc gamma RI that we have defined. These mAb will be useful for additional characterization of Fc gamma RI, and may, when incorporated into tumor-directed heteroantibodies, enhance tumor cell killing by human monocytes and macrophages.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474608

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Increased distribution and expression of CD64 on blood polymorphonuclear cells from patients with the systemic inflammatory response syndrome (SIRS).

Authors:  S S Qureshi; S M Lewis; V A Gant; D Treacher; B H Davis; K A Brown
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

2.  Direct evidence for antibody bipolar bridging on herpes simplex virus-infected cells.

Authors:  K E Van Vliet; L A De Graaf-Miltenburg; J Verhoef; J A Van Strijp
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

Review 3.  Molecular therapy in head and neck oncology.

Authors:  Jacques Bernier; Søren M Bentzen; Jan B Vermorken
Journal:  Nat Rev Clin Oncol       Date:  2009-05       Impact factor: 66.675

4.  F(c)gammaRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonist T cell epitopes.

Authors:  C Liu; J Goldstein; R F Graziano; J He; J K O'Shea; Y Deo; P M Guyre
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

5.  CD89-mediated recruitment of macrophages via a bispecific antibody enhances anti-tumor efficacy.

Authors:  Bingyu Li; Lijun Xu; Chenyu Pi; Yanxin Yin; Kun Xie; Fei Tao; Renhao Li; Hua Gu; Jianmin Fang
Journal:  Oncoimmunology       Date:  2017-10-12       Impact factor: 8.110

6.  Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils.

Authors:  L A Sanders; R G Feldman; M M Voorhorst-Ogink; M de Haas; G T Rijkers; P J Capel; B J Zegers; J G van de Winkel
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

7.  Isotype-specific cross-linking of select human Fc gamma R isoforms triggers release of IL-6.

Authors:  A J Duits; L A Aarden; L K Ernst; P J Capel; J G van de Winkel
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

8.  Design of a transferrin-proteinase inhibitor conjugate to probe for active cysteine proteinases in endosomes.

Authors:  R Xing; R W Mason
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

9.  On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2.

Authors:  P W Parren; P A Warmerdam; L C Boeije; J Arts; N A Westerdaal; A Vlug; P J Capel; L A Aarden; J G van de Winkel
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

10.  Comparative efficiencies of bispecific F(ab'gamma)2 and chimeric mouse/human IgG antibodies in recruiting cellular effectors for cytotoxicity via Fc gamma receptors.

Authors:  J Greenman; N Hogg; S Nikoletti; C Slade; G Stevenson; M Glennie
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.